Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.
Brennan PN, MacMillan M, Manship T, Moroni F, Glover A, Troland D, MacPherson I, Graham C, Aird R, Semple SIK, Morris DM, Fraser AR, Pass C, McGowan NWA, Turner ML, Manson L, Lachlan NJ, Dillon JF, Kilpatrick AM, Campbell JDM, Fallowfield JA, Forbes SJ.
Brennan PN, et al. Among authors: turner ml.
Nat Med. 2025 Jan 10. doi: 10.1038/s41591-024-03406-8. Online ahead of print.
Nat Med. 2025.
PMID: 39794616